Affimed N.V. (AFMD): OrbiMed Advisors Cuts Its Position

Page 3 of 12

Page 3 of 12 – SEC Filing
3 of 12
CUSIP No.  N01045108
 
  
   
1
NAME OF REPORTING PERSONS
OrbiMed Capital GP III LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
                          
                               
(a) o
(b) o
3
SEC USE ONLY
4
SOURCE OF FUNDS (See Instructions)
N/A
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
0
8
SHARED VOTING POWER
3,343,965*
9
SOLE DISPOSITIVE POWER
0
10
SHARED DISPOSITIVE POWER
3,343,965*
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,343,965*
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.05%†
14
TYPE OF REPORTING PERSON (See Instructions)
OO
___________________________
* Includes 323,623 shares that may be transferred pursuant to the Carve-Out Agreements described in Item 6.
† This percentage is calculated based upon 33,259,404 shares of the Issuer’s Common Stock (as defined below) outstanding, as set forth in the Issuer’s Annual Report on Form 20-F, filed with the Securities and Exchange Commission (the “SEC”) on March 30, 2016.

Follow Affimed N.v. (NASDAQ:AFMD)

Page 3 of 12